首页>
外国专利>
USE OF NEUTRALIZING PROLACTIN RECEPTOR ANTIBODIES FOR THE TREATMENT AND PREVENTION OF ANTIESTROGEN-RESISTANT BREAST CANCER
USE OF NEUTRALIZING PROLACTIN RECEPTOR ANTIBODIES FOR THE TREATMENT AND PREVENTION OF ANTIESTROGEN-RESISTANT BREAST CANCER
展开▼
机译:中和催乳素受体抗体在抗癌抗乳腺癌的治疗和预防中的应用
展开▼
页面导航
摘要
著录项
相似文献
摘要
The use, respectively the method of use of neutralizing Prolactin receptor antibodies (PRLR antibodies) for the treatment and prevention of antiestrogen-resistant breast cancer is described. These antibodies can be combined with one ore more of several other cytotoxic agents, when used in treatment and prevention of antiestrogen- resistant breast cancer.
展开▼